Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal Subjects
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01084850|
Recruitment Status : Unknown
Verified January 2010 by Frederiksberg University Hospital.
Recruitment status was: Recruiting
First Posted : March 11, 2010
Last Update Posted : March 11, 2010
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Observational Model:||Case Control|
|Official Title:||Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal Subjects|
|Study Start Date :||June 2009|
|Estimated Primary Completion Date :||June 2010|
|Estimated Study Completion Date :||September 2010|
Diabetes Type II
Patients with type 2 Diabetes Mellitus
Patients with no diabetes
- Corneal endothelium cell number [ Time Frame: 1 year ]The study is a cross-sectional study. We compare a cohort of patients with DM to a cohort with no DM. We examine each patient and control once. We call time of appointment or examination for "at entry to study".
- Corneal endothelium morphology [ Time Frame: 1 year ]The size and hexagonality of the cells are analysed automaticly by computer recognizion.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01084850
|Contact: Allan Storr-Paulsen, MDfirstname.lastname@example.org|
|Frederiksberg University Eye Clinque||Recruiting|
|Frederiksberg, Denmark, 2000|
|Contact: Allan Storr-Paulsen, MD +4538163646 email@example.com|
|Study Chair:||Jens C Norregaard, MD, phd||Frederiksberg University Hospital, Eye Clinque|